Mostrar 1 - 3 resultats de 3 per cerca 'M Cappellini', hora de la petició: 0.02sec Refinar resultats
  1. 1
    P112: ENERGIZE AND ENERGIZE-T: TWO PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDIES OF MITAPIVAT IN ADULTS WITH NON--TRANSFUSION-DEPENDENT OR TRANSFUSION-DEPENDENT ALPHA- OR BETA-THALASSEMIA

    P112: ENERGIZE AND ENERGIZE-T: TWO PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDIES OF MITAPIVAT IN ADULTS WITH NON--TRANSFUSION-DEPENDENT OR TRANSFUSION-DEPENDENT ALP... per K Kuo, D Layton, H Al-Samkari, A Kattamis, S Sheth, A Taher, V Viprakasit, C Chamberlain, L Czapla, S Gheuens, M Lynch, B Tong, K Uhlig, M Cappellini

    Publicat 2022-01-01
    Obtenir text complet
    Article
  2. 2
    5612617 EFFICACY AND SAFETY OF A SINGLE DOSE OF EXAGAMGLOGENE AUTOTEMCEL FOR TRANSFUSION-DEPENDENT-THALASSEMIA AND SEVERE SICKLE CELL DISEASE

    5612617 EFFICACY AND SAFETY OF A SINGLE DOSE OF EXAGAMGLOGENE AUTOTEMCEL FOR TRANSFUSION-DEPENDENT-THALASSEMIA AND SEVERE SICKLE CELL DISEASE per J. de la Fuente, F. Locatelli, H. Frangoul, S. Corbacioglu, D. Wall, M. Cappellini, M. de Montalembert, A. Kattamis, S. Lobitz, D. Rondelli, S. Sheth, M. Steinberg, M. Walters, Y. Bobruff, C. Simard, Y. Song, L. Zhang, A. Sharma, S. Imren, B. Hobbs, S. Grupp

    Publicat 2023-04-01
    Obtenir text complet
    Article
  3. 3
    S106: LONG-TERM FOLLOW-UP OF BETA-THALASSEMIA PATIENTS TREATED WITH HEMATOPOIETIC STEM CELL GENE THERAPY

    S106: LONG-TERM FOLLOW-UP OF BETA-THALASSEMIA PATIENTS TREATED WITH HEMATOPOIETIC STEM CELL GENE THERAPY per S Marktel, S Scaramuzza, F Giglio, M Cicalese, M Lidonnici, C Rossi, V Calbi, N Masera, E D’Angelo, N Mirra, R Origa, I Tartaglione, S Perrotta, G Viarengo, L Santoleri, R Milani, S Gattillo, A Calabria, E Montini, G Graziadei, L Naldini, M Cappellini, A Aiuti, F Ciceri, G Ferrari

    Publicat 2022-01-01
    Obtenir text complet
    Article

Eines de cerca: